Fig. 2From: Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysisForest plot describing the difference between Anakinra compared to placebo or standard care alone regarding all-cause mortality at up to day 28. M–H Mantel–HaenszelBack to article page